Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | 3C4H4O6.2Bi |
| Molecular Weight | 862.1737 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 6 / 6 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[Bi+3].[Bi+3].O[C@H]([C@@H](O)C([O-])=O)C([O-])=O.O[C@H]([C@@H](O)C([O-])=O)C([O-])=O.O[C@H]([C@@H](O)C([O-])=O)C([O-])=O
InChI
InChIKey=SULICOHAQXOMED-YDXPQRMKSA-H
InChI=1S/3C4H6O6.2Bi/c3*5-1(3(7)8)2(6)4(9)10;;/h3*1-2,5-6H,(H,7,8)(H,9,10);;/q;;;2*+3/p-6/t3*1-,2-;;/m111../s1
| Molecular Formula | Bi |
| Molecular Weight | 208.9804 |
| Charge | 3 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | C4H4O6 |
| Molecular Weight | 148.071 |
| Charge | -2 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
Doses
| Dose | Population | Adverse events |
|---|---|---|
0.5 g 1 times / 2 weeks multiple, intravenous Studied dose Dose: 0.5 g, 1 times / 2 weeks Route: intravenous Route: multiple Dose: 0.5 g, 1 times / 2 weeks Sources: |
unhealthy, 39 years n = 1 Health Status: unhealthy Condition: rheumatoid arthritis. Age Group: 39 years Sex: F Population Size: 1 Sources: |
Other AEs: Nephrotic syndrome... |
650 mg 1 times / day single, intravenous Studied dose Dose: 650 mg, 1 times / day Route: intravenous Route: single Dose: 650 mg, 1 times / day Sources: |
unhealthy, adult n = 2 Health Status: unhealthy Condition: yaws Age Group: adult Sex: F Population Size: 2 Sources: |
Other AEs: Death... |
AEs
| AE | Significance | Dose | Population |
|---|---|---|---|
| Nephrotic syndrome | 0.5 g 1 times / 2 weeks multiple, intravenous Studied dose Dose: 0.5 g, 1 times / 2 weeks Route: intravenous Route: multiple Dose: 0.5 g, 1 times / 2 weeks Sources: |
unhealthy, 39 years n = 1 Health Status: unhealthy Condition: rheumatoid arthritis. Age Group: 39 years Sex: F Population Size: 1 Sources: |
|
| Death | 650 mg 1 times / day single, intravenous Studied dose Dose: 650 mg, 1 times / day Route: intravenous Route: single Dose: 650 mg, 1 times / day Sources: |
unhealthy, adult n = 2 Health Status: unhealthy Condition: yaws Age Group: adult Sex: F Population Size: 2 Sources: |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:26:34 GMT 2023
by
admin
on
Fri Dec 15 15:26:34 GMT 2023
|
| Record UNII |
DKV172B7RB
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
229-530-2
Created by
admin on Fri Dec 15 15:26:34 GMT 2023 , Edited by admin on Fri Dec 15 15:26:34 GMT 2023
|
PRIMARY | |||
|
6591-56-6
Created by
admin on Fri Dec 15 15:26:34 GMT 2023 , Edited by admin on Fri Dec 15 15:26:34 GMT 2023
|
PRIMARY | |||
|
DKV172B7RB
Created by
admin on Fri Dec 15 15:26:34 GMT 2023 , Edited by admin on Fri Dec 15 15:26:34 GMT 2023
|
PRIMARY | |||
|
3080629
Created by
admin on Fri Dec 15 15:26:34 GMT 2023 , Edited by admin on Fri Dec 15 15:26:34 GMT 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
SOLVATE->ANHYDROUS |
